Publications

PHYSICIANS

Mundt Pubs

Sandhu Pubs

Yashar Pubs

Rose Pubs


Publications for Arno James Mundt, M.D.
Chairman, Department of Radiation Oncology

Original Peer Reviewed Publications
Other Publications
UpToDate Publications
On-Line Atlas
Book Chapters
Books

Original Peer Reviewed Publications

  1. Li C, Crawford S, Mundt AJ, Vijayakumar S. Computer-aided treatment design of a distal upper extremity soft tissue tumor with electron beam radiotherapy. Med Dosim 1993;18:143-8.



  2. Mundt, A.J., Sibley, G., Williams, S., Rubin, S., Halpern, H., Heimann, R., Weichselbaum, R. Patterns of Failure and Outcome of Complete Responders Following High-Dose Chemotherapy and Autologous Bone Marrow Transplantation for Metastatic Breast Cancer. Int J Radiat Oncol  Biol  Phys 30:151-160, 1994.

    3. See Editorial
    Marks LB, Prosnitz LR. Is there a role for radiotherapy in the “curative” management of patients with metastic cancer? Int J Radiat Oncol Biol Phys 1994;30:243-4.

  3. Mundt, A.J., Awan, A.J., Sibley, G., Simon, M., Rubin, S., Samuels, B., Wong, W., Beckett, M., Vijayakumar, S., Weichselbaum, R. Conservative Surgery and Adjuvant Radiation Therapy in the Management of Adult Soft Tissue Sarcoma of the Extremities: Clinical and Radiobiologic Results.  Int J Radiat Oncol Biol Phys 32:977-985, 1995.

    4. See Editorial
    Suit H. Sarcoma of soft tissues: radiation sensitivity, treatment field margins, pathological margins, and dose. Int J Radiat Oncol Biol Phys 1995;32:1545-6.

  4. Mundt, A.J., Sibley, G., Williams, S. Hallahan, D., Weichselbaum, R. Patterns of Failure and Outcome Following High-Dose Chemotherapy and Bone Marrow Transplantation With Involved Field Radiotherapy for Relapsed/Refractory Hodgkin's Disease.
    Int J Radiat Oncol Biol Phys 33:261-270,1995.

    5. See Editorial
    Yahalom J. Integrating radiotherapy into bone marrow transplantation programs for Hodgkin's disease. Int J Radiat Oncol Biol Phys 1995;33:525-8.

  5. Sibley, G., Mundt, AJ, Goldman, S., Nachman, J., Johnson, L., Weichselbaum, R., Hallahan, D. The Patterns of Failure Following Total Body Irradiation and Bone Marrow Transplantation +/- Local Radiation Therapy Boost for Advanced Neuroblastoma  Int  J Radiat  Oncol  Biol Phys 32:1127-1135, 1995.



  6. Roeske, J., Kuchnir, F., Mundt, AJ, Haraf, D. Photon and Electron Field Matching in the Treatment of Tumors of the Paranasal Sinuses: A Case Report.  Med Dosim. 21:31-36, 1996.


  7. Sibley, G., Mundt, A.J., Shapiro C., Jacobs R., Chen G., Weichselbaum R., Vijayakumar, S. Treatment of Stage III Non-Small Cell Lung Cancer Using High Dose Conformal Radiotherapy.  Int.  J. Radiat.  Oncol.  Biol.  Phys. 33:1001-1007, 1995.



  8. Chen L., Mundt, A.J., Powers C., Halpern H., Weichselbaum R. Significance of family history in breast cancer treated with breast conservation therapy.  Breast J. 2:238-245, 1996


  9. Jaffey P., Mundt, A.J., Baunoch D., Armstron D., Hamilton W., Zagaya V., Grossman R., Wollman R. The clinical significance of extracellular matrix in gangliogliomas.  J Neuropath Exp Neurol 55:1246-1252, 1996.



  10. Gibbs P., Peabody T., Mundt, A.J., Montag A., Simon M. Oncologic Outcomes of Subcutaneous Sarcomas of the Extremities.  J Bone J Surg 79A:888-897, 1997.


  11. Roeske J., Mundt, A.J., Halpern H., Sweeney P., Sutton H., Powers C., Rotmensch J., Waggoner S., Fleming G., Weichselbaum R. Late rectal sequelae following definitive radiation therapy for carcinoma of the uterine cervix: a dosimetric analysis.  Int.  J. Radiat.  Oncol.  Biol.  Phys. 37:351-358, 1997.


  12. Mundt, A.J., Williams, S.F., Hallahan, D.E.  Patterns of failure and outcome of patients with aggressive non-Hodgkin's lymphoma undergoing high dose chemotherapy and stem cell rescue.  Int.  J. Radiat.  Oncol.  Biol.  Phys. 39:617-626, 1997.



  13. Kowalczuk A., Macdonald R.L., Amidei, C., Dohrmann, G., Erickson ,R.K., Hekmatpanah, J., Krauss, S., Krishnasamy, S., Masters, G., Mullan, S.F., Mundt, A.J., Sweeney, P., Vokes, E.E., Weir, B.K.A., Wollman, R.L.  Quantitative imaging study of extent of surgical resection and prognosis of malignant astrocytomas.  Neurosurgery 41:1028-1038, 1997


  14. Mitchell, P.A., Rotmensch, J., Waggoner, S., Mundt, A.J.  Radiation therapy in elderly patients with cervical carcinoma.  Gynecol Oncol 71:291-298, 1998.



  15. Mundt, A.J., Connell, P.P., Campbell, T., Hwang, J., Rotmensch, J., Waggoner, S. Race and clinical outcome in patients with cervical carcinoma undergoing radiation therapy. Gynecol Oncol 71:151-158. 1998.


    16. See Editorial
    Parham G, Hicks M. Race as a Factor in the Outcome of Patients with Cervical Cancer: Lift the Veil to Find the Wounded Spirit. Gynecol Oncol 1998;71:149-150.

  16. Mundt, A.J., Rotmensch, J., Waggoner, S., Quiet, C., Fleming, G. Phase I trial of concomitant chemoradiotherapy for cervical cancer and other advanced pelvic malignancies.  Gynecol Oncol 72:45-50, 1999.


  17. Mundt, A.J., Waggoner, S., Rotmensch, J., Herbst, A.J. Preoperative intracavitary brachytherapy in early stage cervical carcinoma,  Am J Clin Oncol 22:737-7, 1999.


  18. Weiss, M., Connell, P.P., Rotmensch, J., Waggoner, S., Mundt A.J.  External pelvic radiation therapy in stage IC endometrial carcinoma, Obstet Gynecol 93:599-602, 1999.


  19. Czyzewski, E.A.D., Goldman, S., Mundt, A.J., Nachman, J., Rubin, C., Hallahan, D.E.  Radiation therapy for consolidation of metastatic or recurrent sarcomas in children treated with intensive chemotherapy and stem cell rescue: a feasibility study.  Int J Radiat Oncol Biol Phys 44:569-577, 1999.


  20. Calvin, D., Connell, P.P., Rotmensch, J., Waggoner, S., Mundt, A.J.  Surgery and adjuvant radiation therapy in stage II endometrial carcinoma.  Am J Clin Oncol 22:238-243, 1999.


  21. Connell, P.P., Mansur, D.B., Macdonald, L., Nicholas, K.E., Mundt, A.J. Tumor size predicts control in benign meningiomas.  Neurosurgery 44:1194-1200, 1999.


  22. Connell, P.P., Rotmensch, J., Waggoner, S., Mundt, A.J.  Significance of adnexal involvement in endometrial carcinoma. Gynecol Oncol 74:74-79, 1999.


  23. Connell, P,P., Waggoner, S., Rotmensch, J., Mundt, A.J.  Race and clinical outcome in endometrial carcinoma.  Obstet Gynecol 94:713-20, 1999.


  24. Mundt, A.J., Connell, P.P., Mansur,  D.B.  What is the optimal treatment volume in Hodgkin's disease patients undergoing high dose chemotherapy, stem cell rescue and adjuvant radiation therapy?  Radiat Oncol Invest 7:353-359, 1999


  25. Mansur, D.B., Hekmatpanah, J., Wollman, R., Macdonald, L., Nicholas, K., Beckman, E., Mundt, A.J.  Low grade gliomas treated with adjuvant radiation therapy in the modem imaging era.  Am J Clin Oncol 23:222-6, 2000.


  26. Wollschlaeger, K. Connell, P.P., Waggoner, S., Rotmensch,  J., Mundt, A.J.  Acute problems during low-dose-rate intracavitary brachytherapy for cervical carcinoma,  Gynecol Oncol 76:67-72, 2000.


  27. Tran, B.N., Connell, P.P., Waggoner, S., Rotmensch, J., Mundt, A.J.  Characteristics and outcome of endometrial carcinoma patients age 45 years and younger.  Am J Clin Oncol 23:476-80, 2000.


  28. Mundt, A.J., Connell, P.P.  Do conventional pathologic features lose their prognostic significance following postoperative radiation therapy in pathologic stage 1-H endometrial carcinoma?  Int J Cancer 90:224-30, 2000.


  29. Castro, I,N., Connell, P.P., Waggoner, S., Rotmensch, J., Mundt, A.J.  Synchronous ovarian and endometrial malignancies.  Am J Clin Oncol 23:521-5, 2000.


  30. Rotmensch, J., Connell, P.P., Yamada, D., Waggoner, S.E., Mundt, A.J.  One versus two intracavitary brachytherapy applications in early stage cervical cancer patients undergoing definitive radiation therapy.  Gynecol Oncol 78:32-38, 2000.


  31. Mundt, AJ, Waggoner, S., Yamada, D., Rotmensch, J., Connell, P.P.  Age as a prognostic factor for recurrence in patients with endometrial carcinoma.  Gynecol Oncol 79:79-85, 2000.


  32. Roeske, JC, Lujan, A, Rotmensch, J, Waggoner, SE, Yamada, D., Mundt, AJ. Intensity modulated whole pelvic radiation therapy in patients with gynecological malignancies.  Int J Radiat Oncol Biol Phys 48:1613-21, 2000.

    33. See Commentary
    Petersen I. Intensity modulated whole pelvic radiation therapy in patients with gynecologic malignancies. Roeske JC et al. Int J Radiat Oncol Biol Phys 2000;48:1613-21. Womens Oncol Rev 2001;1:89-90.

  33. Lapeyre M, Hoffstetter S, Peiffert D, Guerif S, Maire F, Dolivet G, Toussaint B, Mundt AJ, Chassagne JF, Simon C, Bey P. Postoperative brachytherapy alone for T1-2 N0 squamous cell carcinomas of the oral tongue and floor of mouth with close or positive margins.  Int J Radiat Oncol Biol Phys 48:37-42, 2000.


  34. Mundt AJ. Commentary on “Postoperative pelvic radiotherapy improved locoregional control but not survival in stage I endometrial carcinoma” Creutzberg CL, van Putten WLJ, Koper PCM, et al. Lancet 2000;355:1404-1411.  Evidence-based Obstet Gynecol 3:46-47, 2001.


  35. Mundt AJ,  Rotmensch  J, Waggoner, S, Yamada SD, Fleming G. Phase I trial of concomitant vinorelbine, paclitaxel and pelvic radiation therapy for cervical cancer and other advanced pelvic malignancies.  Gynecol Oncol 82:333-337, 2001.


  36. Ashman JA, Connell PP, Rotmensch J, Waggoner S, Yamada SD, Mundt AJ.  Outcome and management of endometrial carcinoma patients with involvement of the uterine serosa.  Gynecol Oncol 82:338-343, 2001.


  37. Mundt AJ, McBride R, Rotmensch J, Waggoner SE, Yamada SD, Connell PP. Pelvic recurrence in high-risk pathologic stage I-IV endometrial carcinoma patients following adjuvant chemotherapy alone: implications for adjuvant radiation therapy.  Int J Radiat Oncol Biol Phys 50:1145-53, 2001.


  38. Mundt AJ, Murphy K, Rotmensch J, Waggoner SE, Yamada SD, Connell PP. Surgery and postoperative radiation therapy in FIGO stage IIIC endometrial carcinoma.  Int J Radiat Oncol Biol Phys 50:1154-1160, 2001.


  39. Mundt AJ, Roeske JC, Lujan A, Yamada SD, Waggoner SE, Fleming GF, Rotmensch J. Initial clinical experience using intensity modulated whole pelvic radiation therapy for gynecologic malignancies.  Gynecol Oncol 82:456-63, 2001.


  40. Phelan C, Montag A, Rotmensch J, Yamada SD, Waggoner SE, Mundt AJ. Outcome and management of pathologic stage I endometrial cancer patients with involvement of the lower uterine segment.  Gynecol Oncol 83:513-517, 2001.


  41. Mundt AJ, Lujan AE, Rotmensch J, Waggoner SE, Yamada SD, Fleming G, Roeske JC. Intensity modulated whole pelvic radiation therapy in women with gynecologic malignancies.  Int J Radiat Oncol Biol Phys 52:1330-7, 2002.

    42. See Commentary
    Wolfson A. Intensity modulated whole pelvic radiation therapy in patients with gynecologic malignancies. Mundt AJ et al.  Int J Radiat Oncol Biol Phys 2002;52:1330-7. Womens Oncol Rev 2002;2:345-46.

  42. Mundt AJ, Roeske JC, Lujan AE. Intensity-modulated radiation therapy in gynecologic malignancies.  Med Dosim 27:131-136, 2002.


  43. Mundt AJ. Intensity modulated radiation therapy- a revolution in cancer care.  Men’s Total Health Digest 2:44, 2002.


  44. Brixey C, Roeske JC, Lujan AE, Mundt AJ. Impact of intensity modulated whole pelvic radiation therapy on acute hematologic toxicity in women with gynecologic malignancies.  Int J Radiat Oncol Biol Phys 54:1388-96, 2002.


  45. Mundt AJ, Roeske JC. Can intensity modulated radiation therapy replace brachytherapy in the treatment of patients with cervical cancer? Point.  Brachytherapy 1:192-3, 2002.

    46. See Counterpoint
    Alektiar K. Can intensity modulated radiation therapy replace brachytherapy in the treatment of patients with cervical cancer? Point.  Brachytherapy 1:191-2, 2002.

  46. Murphy K, Rotmensch J, Yamada SD, Mundt AJ. Patterns of failure and outcome of clear cell carcinoma of the uterus: implications for adjuvant radiation therapy.  Int J Radiat Oncol Biol Phys 55:1272-6, 2003.


  47. Mundt AJ, Mell LK, Roeske JC. Prelimary analysis of chronic gastrointestinal toxicity in patients with gynecologic malignancies treated with intensity modulated whole pelvic radiation therapy.  Int J Radiat Oncol Biol Phys 56:1354-1360, 2003.


  48. Torres IJ, Mundt AJ, Sweeney PJ, Llanes-Macy MS, Dunaway L, Macdonald RL. A longitudinal neuropsychological study of partial brain radiation in adults with brain tumors.  Neurology 60:1113-8, 2003.


  49. Mell LK, Roeske JC, Mundt AJ. Survey of intensity modulated radiation therapy use in the United States.  Cancer 98:204-11, 2003.


  50. Mell LK, Mundt AJ. Concern with "Is there a survival benefit to adjuvant radiotherapy in high-risk surgical stage I endometrial cancer?" (Letter to the Editor).  Gynecol Oncol 2003;90:499.


  51. Lujan AE, Mundt AJ, Yamada SD, Rotmensch J, Roeske JC. Intensity-modulated radiotherapy as a means of reducing dose to bone marrow in gynecologic patients receiving whole pelvic radiotherapy.  Int J Radiat Oncol Biol Phys 2003;57:516-21.


  52. Mehta N, Yamada SD, Rotmensch J, Mundt AJ. Outcome and pattern of failure in pathologic stage I-II papillary serous carcinoma of the endometrium: implications for adjuvant radiation therapy.  Int J Radiat Oncol Biol Phys 2003;57:1004-1009.


  53. Engelhard HH, Stelea A, Mundt AJ. Oligodendroglioma and anaplastic oligodendroglioma: clinical features, treatment and prognosis.  Surg Neurol 2003;60:443-56.


  54. Roeske JC, Bonta D, Lujan AE, Mell LK, Yamada SD, Rotmensch J, Mundt AJ. A dosimetric analysis of acute gastrointestinal toxicity in women receiving intensity-modulated whole-pelvic radiation therapy.  Radiother Oncol 2003;69:201-7.


  55. Roeske JC, Lund C, Pelizzari CA, Pan X, Mundt AJ. Reduction of computed tomography metal artifacts due to the Fletcher-Suit applicator in gynecology patients receiving intracavitary brachytherapy.  Brachytherapy 2003;2:207-214.


  56. Brockstein B, Mundt AJ, Haraf DJ, Ferguson M, Montag AG. Radiation-induced leiomyosarcoma: does antimetabolite chemotherapy contribute? A report of three cases.  Sarcoma 2003;7:167-172.


  57. Mundt AJ, Rotmensch J, Waggoner SE, Yamada SD, Fleming GF. Phase I trial of concomitant vinorelbine, cisplatin and pelvic irradiation in cervical carcinoma and other advanced pelvic malignancies.  Gynecol Oncol 2004;92:801-5.


  58. Salama JK, Roeske JC, Mehta N, Mundt AJ. Intensity modulated radiotherapy therapy in gynecologic malignancies.  Curr Treat Options Oncol 2004;5:97-108.


  59. Citron J, Mundt AJ. Pathologic stage I-II endometrial cancer in the elderly: radiotherapy indications and outcome.  Int J Radiat Oncol Biol Phys 2004;59:1432-1438.


  60. Schomas DA, Milano MT, Roeske JC, Mell LK, Mundt AJ. Intensity modulated radiation therapy and the Internet: evaluation of the content and quality of patient-oriented information.  Cancer 2004;101:412-20.

    61. See News Article
    Boggs W. Radiation Therapy Information on the Internet Deemed Poor. Reuters News Health Information. http://www.mercksource.com/pp/us/cns/cns_newsarticleprint Accessed 9/1/04.

  61. Mell LK, Meyer JJ, Tretiakova M, Kramtsov A, Gong C, Yamada SD, Montag AG, Mundt AJ. Prognostic significance of E-cadherin protein expression in pathologic stage I-III endometrial cancer.  Clin Cancer Res 2004;10:5546-53.


  62. Mundt AJ, Vijayakumar S, Nemunaitis J, Sandler A, Schwartz H, Hanna N, Peabody T, Senzer N, Chu K, Rasmussen CS, Kessler PD, Rasmussen HS, Warso M, Kufe DW, Das Gupta T, Weichselbaum RR. A Phase I Trial of TNFerade Biologic in Patients with Soft Tissue Sarcoma in the Extremities.  Clin Cancer Res 2004;10:5747-53.


  63. Mell LK, Mundt AJ. Radiation therapy in the elderly.  Geriatrics Aging 2005;8:50-56


  64. Xia D, Roeske JC, Yu L, Pelizzari CA, Mundt AJ, Pan X. A hybrid approach to reducing computed tomography metal artifacts in intracavitary brachytherapy. Brachytherapy 2005;4:18-23


  65. Haslam JJ, Lujan AE, Mundt AJ, Bonta DV, Roeske JC. Setup errors in patients treated with intensity modulated whole pelvic radiation therapy for gynecological malignancies. Med Dosim 2005;30:36-42.


  66. Schroder M, Mell LK, Hurteau JA, Collins YC, Rotmensch J, Waggoner SE, Yamada SD, Small W, Mundt AJ. Clitoral therapy device for treatment of sexual dysfunction in irradiated cervical cancer patients. Int J Radiat Oncol Biol Phys 2005;61:1078-86.


  67. Schomas DA, Roeske JC, Macdonald RL, Mehta N, Sweeney PJ, Mundt AJ. Predictors of tumor control in patients treated with linac-based stereotactic radiosurgery for metastatic disease to the brain. Am J Clin Oncol 2005;28:180-7


  68. Malik R, Oh JL, Roeske JC, Mundt AJ. Survey of resident education in intensity modulated radiation therapy. Technol Cancer Res Treat 2005;4:303-10


  69. Agulnik M, Rhee EN, Yao M, Mundt AJ, Feldman LE. Paclitaxel, carboplatin and concomitant radiotherapy for resected patients with high risk head and neck cancer. J Chemother 2005;17:237-41.


  70. Modi BJ, Knab B, Feldman LE, Mundt AJ, Yao M, Pytynia KB, Epstein J. Review of current treatment practices for carcinoma of the head and neck. Expert Opin Pharmacother 2005;6:1143-55


  71. Mundt AJ, Mell LK, Roeske JC. IMRT Utilization. Adv Imaging Oncol Administrators July, 2005.


  72. Mell LK, Mundt AJ.  Survey of IMRT use in the United States, 2004. Cancer 2005;104:1296-1303


  73. Montenegro CR, de Castro Neto AJ, Mundt A. Radioterapia de intensidade modulada pelvica. Câncer Hoje. A Oncologia baseada em Evidencias 2005;3:10-11.


  74. Roeske JC, Lujan A, Reba RC, Penney BC, Yamada SD, Mundt AJ. Incorporation of SPECT bone marrow imaging in intensity modulated whole pelvic radiation therapy treatment planning for gynecologic malignancies. Radiother Oncol 2005;77:11-7


  75. Mell LK, Mundt AJ. Radiation Therapy in the Elderly. Cancer J  2005;11:495-505


  76. Silverberg W, Roeske JC, Mehta N, Mundt AJ. Intensity modulated radiation therapy in gynecologic malignancies. Women’s Oncol Review (in press).


  77. Kochanski J, Mundt AJ. Preliminary Analysis of RTOG 9708: Adjuvant Postoperative Radiotherapy Combined with Cisplatin/Paclitaxel Chemotherapy after Surgery for Patients with High-Risk Endometrial Cancer. Greven K, Winter K, Underhill K, et al. Int J Radiat Oncol Biol Phys 2004;59:168-173. Womens Oncol Rev (in press)


  78. Mell LK, Kochanski JD, Roeske JC, Haslam J, Mehta N, Yamada SD, Hurteau J, Collins Y, Lengyel E, Mundt AJ.  Dosimetric predictors of acute hematologic toxicity in cervical cancer patients treated with concurrent cisplatin and intensity modulated pelvic radiotherapy. Int J Radiat Oncol Biol Phys (in press)


  79. Salama JK, Mundt AJ, Roeske JC, Mehta N. Preliminary outcome and toxicity report of extended field intensity modulated radiation therapy for gynecologic malignancies. Int J Radiat Oncol Biol Phys (in press)


  80. Aydogan B, Wang S, Smith B, Mundt AJ, Roeske JC. IMRT as an alternative to intracavitary HDR vaginal brachytherapy in patients with early stage endometrial cancer. Int J Radiat Oncol Biol Phys (in press)


  81. Salama, JK, Aydogan B, Abcarian H, Nelson RL, Cintron JR, Roeske JC, Sutton HG, Smith B, Mundt AJ.  Intensity Modulated Radiation Therapy for Anal Cancer. Dis Colon Rectum (under review)


  82. Kochanski JD, Mell LK, Roeske JC, Yamada SD, Collings Y, Hurteau J, Mehta N, Lengyel E, Sutton H, Mundt AJ. Outcome of cervical cancer patients treated with intensity-modulated pelvic radiation therapy.  Int J Radiat Oncol Biol Phys (under review)


  83. Kochanski JD, Mell LK, Roeske JC, Mundt AJ. Intensity modulated radiation therapy in gynecologic malignancies: current status and future directions. Clin Adv Hem Oncol (in press)


  84. Knab BR, Roeske JC, Yamada SD, Collings Y, Hurteau J, Mehta N, Lengyel E, Sutton H, Mundt AJ. Outcome of endometrial cancer patients treated with intensity-modulated pelvic radiation therapy.  Int J Radiat Oncol Biol Phys (under review) Return to Top

Other Publications

  1. Mundt AJ, Roeske JC, Lujan A. “The University Of Chicago Explores the Role of IMRT in Gynecologic Malignancies.” IMRT Insider. Varian Associates. December 2000


  2. Mundt AJ, Roeske JC, Johnson LS. “Intensity-Modulated Radiation Therapy:
    Revolution in the Treatment of Cancer.” University of Chicago Clinical Comment. Fall, 2000


  3. Mundt AJ, Johnson S. Clinical outcome studies in IMRT: a literature review. Varian Centerline Magazine. Fall, 2000 Return to Top

UpToDate Publications

  1. Chen LM, Mundt AJ, Berek JS. Staging and treatment of endometrial cancer. I. http://www.uptodate.com


  2. Chen LM, Mundt AJ, Berek JS. Staging and treatment of endometrial cancer. II. http://www.uptodate.com


  3. Chen LM, Mundt AJ, Berek JS. Staging and treatment of endometrial cancer. III. http://www.uptodate.com


  4. Goff B, Mundt AJ. Uterine papillary serous and clear cell cancer. http://www.uptodate.com


  5. Memarzadeh S, Mundt AJ, Berek JS. Uterine sarcoma. I. http://www.uptodate.com


  6. Memarzadeh S, Mundt AJ, Berek JS. Uterine sarcoma. II. http://www.uptodate.com

On-Line Atlas

  1. Small W, Mundt AJ.  Gynecologic Pelvic (IMRT) Atlas.  http://www.rtog.org/gynatlas/main.html Return to Top

Book Chapters

  1. Drinkard, L.C., Ferguson, M.K., Mundt, AJ, Vokes, E.E.  Therapy of Esophageal Cancer.  In: Aisner, J., Arriagada, R., Green, M.R., Martini, N., Perry, M.C. (eds).  Comprehensive Textbook of Thoracic Oncology.  Williams & Wilkins, Baltimore, 1996.


  2. Mundt, AJ, Weichselbaum, R.R.  Radiation Therapy in Soft Tissue Tumors.  In: Das Gupta T (ed). Soft Tissue Tumors.  Williams & Wilkins, Baltimore, 1996.


  3. Mundt, AJ  Principles of Radiation Therapy.  In: Golomb H, Vokes EE (eds). 1st Edition. Oncologic Therapeutics.  Springer-Verlag, Heidelberg, 1998.


  4. Mundt, AJ, Roeske, JC, Weichselbaum, R.R.  Principles of Radiation Oncology.  In: Holland J, Frei E, Weichselbaum RR (eds). Cancer Medicine. B.C. Decker, Toronto, 1999.


  5. Mundt, AJ  Radiation Therapy and the Elderly.  In: Hunter CP, Johnson KA, Muss HB (eds). Cancer in the Elderly.  Marcel Dekker, Inc., New York, 2000.


  6. 6. Mundt, AJ, Roeske, JC.  Principles of Radiation Therapy.  In: Golomb H, Vokes EE (eds). Oncologic Therapeutics. 2nd Edition.  Springer-Verlag, Heidelberg, 2001.


  7. Mundt AJ, Roeske JC, Chung T, Weichselbaum RR. Principles of Radiation Oncology.  In: Holland J, Frei E, Weichselbaum RR (eds). Cancer Medicine. B.C. Decker, Toronto, 2002.


  8. Mundt AJ, Artioli G, Fleming GF. Treatment of Recurrent Endometrial Cancer: Chemotherapy, Hormonal therapy, and Radiation Therapy. In: Gershenson, Gore, McGuire, Quinn, Thomas (eds).  Gynecologic Cancer: Controversies in Management. Elsevier Science (USA), Philadephia, 2002.


  9. Rowinsky E, Mundt AJ. 21st Century Innovative Therapies. In: Hoskins WJ, Perez CA, Young RC (eds).  Principles and Practice of Gynecologic Oncology. J.B. Lippincott, Philadelphia, 2004.


  10. Burke T, Muggia F, Mundt AJ. Uterine Cancer. In: Devita V, Hellman S, Rosenberg (eds).  Principles and Practice of Oncology.  Williams and Wilkins, Baltimore, 2005.


  11. Fleming GF, Montag AC, Mundt AJ, Yamada SD.  Uterine Malignancies.  In: Chang AE, Ganz PA, Hayes DF et al. (Editors).  Oncology: An Evidence-Based Approach. Blackwell Publishing Ltd, Oxford, 2005.


  12. Mundt AJ, Wyman B, Chotipradit C, Bruch P, Roeske JC. The IMRT Process. In: Mundt AJ, Roeske JC (eds).  Intensity Modulated Radiation Therapy: A Clinical Perspective. B.C. Decker, Toronto, 2005.


  13. Mell LK, Mehta N, Roeske JC, Mundt AJ. Gynecologic Malignancies. In: Mundt AJ, Roeske JC (eds). Intensity Modulated Radiation Therapy: A Clinical Perspective. B.C. Decker, Toronto, 2005.


  14. Kao J, Mundt AJ. Metastatic and Recurrent Disease. In: Mundt AJ, Roeske JC (eds).  Intensity Modulated Radiation Therapy: A Clinical Perspective. B.C. Decker, Toronto, 2005.


  15. Roeske JC, Mundt AJ. Bone Marrow Sparing Approaches.  In: Mundt AJ, Roeske JC (eds).  Intensity Modulated Radiation Therapy: A Clinical Perspective. B.C. Decker, Toronto, 2005.


  16. Mundt AJ, Roeske JC, Chung T, Weichselbaum RR. Principles of Radiation Oncology.  In: Holland J, Frei E, Weichselbaum RR (eds).  Cancer Medicine. B.C. Decker, Toronto, 2005. Return to Top
Books
  1. Cancer Medicine Review. Stone, R.M., Essner, R., Mundt, A.J. (eds).  Williams & Wilkins, Baltimore, 1997.


  2. Intensity Modulated Radiation Therapy: A Clinical Perspective. Mundt AJ, Roeske JC (eds). B.C. Decker, Toronto, 2005. Return to Top


Home  |  Patient Information | Faculty & Staff  | Centers  | Referring Physicians
Education  | Research  | Giving  | Employment  | Search

This site is a service of the Radiation Oncology Department at the Moores UCSD Cancer Center.  Please read the terms and conditions
of use before using this site. Comments or questions?  Please contact our webmaster. Radiation Oncology faculty and staff site.